Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radiopharmaceutical”

118 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 118 results

Not applicableStudy completedNCT00001385
What this trial is testing

Positron Emission Tomography in Patients With Breast Cancer

Who this might be right for
Breast Neoplasms
National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)Ended earlyNCT01898273
What this trial is testing

Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Cellectar Biosciences, Inc. 7
Early research (Phase 1)Looking for participantsNCT07581184
What this trial is testing

[225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Resistant Metastatic Prostate CancerProstate CancermCRPC (Metastatic Castration-resistant Prostate Cancer)+2 more
Aktis Oncology, Inc. 138
Testing effectiveness (Phase 2)Looking for participantsNCT06710756
What this trial is testing

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaGastric CancerEsophageal Cancer+5 more
Perspective Therapeutics 112
Very early researchLooking for participantsNCT07067346
What this trial is testing

Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Sichuan University 10
Very early researchNot Yet RecruitingNCT07280793
What this trial is testing

CAR-T Cell Efficacy With Molecular Imaging in Multiple Myeloma

Who this might be right for
Non-invasive CAR-T Cell MonitoringBCMA-targeted PET ImagingCAR-T Cell Biodistribution and Persistence+1 more
Xuzhou Medical University 10
Not applicableLooking for participantsNCT07174089
What this trial is testing

New AI-based Technologies in Nuclear Medicine

Who this might be right for
Patients Undergoing PET/CT Investigation or Nuclear Medicine Therapy
Azienda USL Reggio Emilia - IRCCS 1,500
Not applicableLooking for participantsNCT06000787
What this trial is testing

MCT for the Harvard/UCSF ROBIN Center

Who this might be right for
Glioma, Childhood BrainstemNeuroblastoma
Brigham and Women's Hospital 47
Not applicableStudy completedNCT00245349
What this trial is testing

Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Iowa 9
Testing effectiveness (Phase 2)Ended earlyNCT06939036
What this trial is testing

Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 )

Who this might be right for
Small Cell Lung Cancer Extensive StageMerkel Cell Carcinoma
Ariceum Therapeutics GmbH 2
Very early researchNot Yet RecruitingNCT07639970
What this trial is testing

Evaluation of [⁶⁸Ga/¹⁷⁷Lu]HT547: Safety, Biodistribution, and Dosimetry in Solid Tumors

Who this might be right for
Breast CancerHead and Neck Cancer (H&N)Pancreatic Cancer+1 more
Hua Pang 20
Not applicableEnded earlyNCT01519973
What this trial is testing

Optimization of SPECT Imaging

Who this might be right for
Coronary Artery Disease
Ottawa Heart Institute Research Corporation 64
Not applicableLooking for participantsNCT06700057
What this trial is testing

Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.

Who this might be right for
Prostate CancerMetastasis
Institut Bergonié 50
Not applicableStudy completedNCT04812301
What this trial is testing

Abbott Vital® as an Alternative Meal to the Gold-standard Egg-white Sandwich for Gastric Emptying Scintigraphy (GES)

Who this might be right for
Healthy
Universiti Sains Malaysia 30
Testing effectiveness (Phase 2)Ended earlyNCT02149017
What this trial is testing

Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F)

Who this might be right for
Alzheimer Disease
Seoul National University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01240551
What this trial is testing

F-18 Sodium Fluoride in Prostate Cancer

Who this might be right for
Prostate Neoplasm
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)UnknownNCT03561259
What this trial is testing

Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects

Who this might be right for
NeuroblastomaNeuroectodermal TumorsNeoplasms
Jubilant DraxImage Inc. 60
Early research (Phase 1)Study completedNCT03030885
What this trial is testing

Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate CancerMetastatic Castration-Resistant Prostate Cancer (mCRPC)
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT03207139
What this trial is testing

Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer

Who this might be right for
Latent Cancer Prostate
Chang Gung Memorial Hospital 71
Testing effectiveness (Phase 2)Looking for participantsNCT06726161
What this trial is testing

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
RayzeBio, Inc. 590
Load More Results